Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you consider definitive XRT for high-grade sarcomatoid bladder ca s/p TURBT in an inoperable patient?
Related Questions
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
In light of the recent data indicating increased late grade 3 to 5 toxicities (LTOX3) after hypofractionated salvage radiation therapy, will you continue to offer these regimes to patients?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?
Under what circumstances would you treat prostate cancer without a biopsy?
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How do you manage a prostate cancer patient with pelvic lymphadenopathy and a single enlarged PSMA PET+ gastrohepatic node?
How often do you utilize intrafraction motion tracking when treating prostate cancer?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
What are your top takeaways in GU Cancers from ASCO 2025?
